
Results
11
The top dividend paying companies in the stock market today.
11 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.9b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$9.43
7D
7.5%
1Y
17.9%
Tong Ren Tang Technologies
Market Cap: HK$6.3b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.93
7D
5.6%
1Y
-3.3%
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.00
7D
-0.07%
1Y
76.3%
Essex Bio-Technology
Market Cap: HK$2.6b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.61
7D
5.5%
1Y
75.3%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.6b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$7.22
7D
3.4%
1Y
22.0%
CSPC Pharmaceutical Group
Market Cap: HK$87.6b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$7.95
7D
5.3%
1Y
53.2%
Shanghai Haohai Biological Technology
Market Cap: HK$11.8b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$28.12
7D
1.4%
1Y
-4.4%
China Shineway Pharmaceutical Group
Market Cap: HK$6.9b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$9.17
7D
3.3%
1Y
10.1%
Pak Fah Yeow International
Market Cap: HK$751.1m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.41
7D
-1.6%
1Y
0.8%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.17
7D
-0.8%
1Y
-6.4%
Jacobson Pharma
Market Cap: HK$2.9b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.46
7D
1.4%
1Y
94.7%